Immune Recovery following Antineoplastic Chemotherapy and Highly Active Antiretroviral Therapy (Haart) in a Child with HIV-1 Infection Previously Unresponsive to Haart

Abstract

We report the case of a perinatally HIV-1-infected child, previously immunologically unresponsive to antiretroviral treatments (including the highly active antiretroviral therapy), who instead developed a vigorous and long-lasting immune response after the highly active antiretroviral therapy was associated with antineoplastic chemotherapy undertaken for a B-cell non-Hodgkin bone lymphoma.